Article Information
History
- February 8, 2019.
Article Versions
- You are currently viewing Version 1 of this article (February 8, 2019 - 18:05).
- View Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Renjie Liao1,†,
- Manas Mondal1,†,
- Christopher D. Nazaroff1,2,
- Diego Mastroeni3,4,
- Paul D. Coleman3,4 and
- Jia Guo1,*
- 1Biodesign Institute & School of Molecular Sciences, Arizona State University, Tempe, Arizona 85287, USA
- 2Division of Pulmonary Medicine, Department of Biochemistry and Molecular Biology, Mayo Clinic Arizona, Scottsdale, Arizona 85259, USA
- 3ASU-Banner Neurodegenerative Disease Research Center, Biodesign Institute and School of Life Sciences, Arizona State University, Tempe, Arizona 85287, USA
- 4L.J. Roberts Center for Alzheimer’s Research, Banner Sun Health Research Institute, Sun City, Arizona 85351, USA
- ↵*Correspondence and requests for materials should be addressed to J.G. (email: jiaguo{at}asu.edu)
↵† These authors contributed equally: Renjie Liao, Manas Mondal.
Posted February 08, 2019.
Highly sensitive in situ proteomics with cleavable fluorescent tyramide reveals human neuronal heterogeneity
